Return on average equity - 5 year average | 6.32 |
Net Income/employee - trailing 12 month | - |
Revenue/employee - most recent fiscal year | - |
Return on investment - most recent fiscal year | 1.81 |
Return on average assets - most recent fiscal year | 1.26 |
Receivables turnover - most recent fiscal year | 0.43 |
Return on investment - trailing 12 month | 1.81 |
Return on average assets - trailing 12 month | 1.26 |
Inventory turnover - most recent fiscal year | 0.60 |
Inventory turnover - trailing 12 month | 0.60 |
Revenue/employee - trailing 12 month | - |
Return on average assets - 5 year average | 3.82 |
Net Income/employee - most recent fiscal year | - |
Return on average equity - trailing 12 month | 1.81 |
Receivables turnover - trailing 12 month | 0.43 |
Asset turnover - most recent fiscal year | 0.11 |
Asset turnover - trailing 12 month | 0.11 |
Return on average equity - most recent fiscal year | 1.81 |
Return on investment - 5 year average | 6.32 |
EVOQ REMEDIES-MT Dividend EVOQ REMEDIES-MT Bonus EVOQ REMEDIES-MT News EVOQ REMEDIES-MT AGM EVOQ REMEDIES-MT Rights EVOQ REMEDIES-MT Splits EVOQ REMEDIES-MT Board Meetings EVOQ REMEDIES-MT Shareholdings EVOQ REMEDIES-MT Profit Loss EVOQ REMEDIES-MT Balance Sheet EVOQ REMEDIES-MT Cashflow EVOQ REMEDIES-MT Q1 Results EVOQ REMEDIES-MT Q2 Results EVOQ REMEDIES-MT Q3 Results EVOQ REMEDIES-MT Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks